M84.575 Pathological fracture in neoplastic disease, left foot

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Left Foot (ICD-10-CM: M84.575)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the left foot. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the left foot's bone integrity, which may involve primary bone tumors or metastatic spread to these regions.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the left foot, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode bone in these areas, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the foot.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to foot sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the left foot, often with minimal or no trauma.
• Swelling, bruising, or deformity of the affected area.
• Difficulty bearing weight or walking.
• Possible numbness or tingling if nerves are involved.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., X-rays, MRI, or CT scans), and review of the patient's cancer history. Imaging may reveal a fracture line with underlying bone destruction or tumor involvement. Biopsy of the affected bone may be performed to confirm neoplastic disease as the cause. Laboratory tests, such as blood work or tumor markers, may support the diagnosis.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include immobilization (e.g., casting or bracing), surgical fixation (e.g., plates, screws, or rods), and pain management. Systemic cancer therapies (e.g., chemotherapy, radiation, or targeted treatments) are used to control the neoplastic disease. Rehabilitation and physical therapy may aid recovery and restore function.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the extent of bone involvement. Fracture healing may be delayed due to weakened bone. Regular follow-up with oncology and orthopedic specialists is essential to monitor cancer progression, fracture healing, and functional recovery. Long-term management may involve ongoing imaging and bone health assessments.

Complications

• Delayed or nonunion of the fracture due to compromised bone healing.
• Infection, particularly if surgery is performed.
• Nerve damage or vascular compromise from the fracture or treatment.
• Progression of the underlying cancer, potentially worsening bone integrity.
• Chronic pain or functional limitations affecting mobility.

Lifestyle & Prevention

• Maintain bone health through adequate nutrition (e.g., calcium, vitamin D) and weight-bearing exercise, if appropriate.
• Avoid high-impact activities that may increase fracture risk.
• Follow prescribed cancer treatments to control neoplastic disease.
• Use assistive devices (e.g., crutches, orthotics) to reduce stress on the affected foot.
• Attend regular medical appointments to monitor bone and cancer status.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe pain in the left foot, swelling, deformity, or inability to bear weight, especially if you have a history of cancer. Prompt evaluation is critical to diagnose and treat the fracture and underlying condition effectively.

Tips for Medical Coders

When coding M84.575, ensure documentation specifies the pathological fracture is due to neoplastic disease and involves the left foot. Verify the fracture is not attributed to trauma alone, as this distinguishes it from other fracture codes. Include details about the underlying cancer (e.g., primary or metastatic) if available, as this supports the neoplastic etiology. Accurate documentation of the anatomical site (left foot) and fracture type is essential for correct code assignment.